Cargando…

Targeting copper to combat macrophage-driven inflammation: a potential advanced therapeutic strategy

Detalles Bibliográficos
Autor principal:	Weiskirchen, Ralf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493218/ https://www.ncbi.nlm.nih.gov/pubmed/37691051 http://dx.doi.org/10.1038/s41392-023-01592-4

Ejemplares similares

Combating COVID-19 with Chloroquine
por: Hong, Wanjin
Publicado: (2020)

Copper boosts pro-inflammatory state of macrophages
por: Flemming, Alexandra
Publicado: (2023)

Boosting T cell immunity against cytomegalovirus: a potential strategy combating human aging and age-related diseases
por: Wirth, Matthias, et al.
Publicado: (2023)

Importance of producing economic compounds to combat cancer
por: Muñoz‐Rojas, Jesús
Publicado: (2017)

In search for novel strategies towards neuroprotection and neuroregeneration: is PPARα a promising therapeutic target?
por: Moreno, Sandra, et al.
Publicado: (2015)

Modeling and combating misinformation spread
por: Rastogi, Ananya
Publicado: (2022)

Prostaglandin regulation of type 2 inflammation: From basic biology to therapeutic interventions
por: Oyesola, Oyebola O., et al.
Publicado: (2021)

Targeting menin: a promising therapeutic strategy for susceptible acute leukemia subtypes
por: Di Fazio, Pietro
Publicado: (2023)

Therapeutic utility of immunosuppressive TREM2+ macrophages: an important step forward in potentiating the immune checkpoint inhibitors
por: Alkan, Fulya Koksalar, et al.
Publicado: (2020)

EphB2: potential therapeutic target for Alzheimer’s disease
Publicado: (2011)

Microglial lactate metabolism as a potential therapeutic target for Alzheimer’s disease
por: Zhao, Yingjun, et al.
Publicado: (2022)

Pop in, pop out: a novel gene-targeting strategy for use with CRISPR-Cas9
por: Kühn, Ralf, et al.
Publicado: (2015)

‘nAb’ the self-reactive activity in the COVID-19 combat
por: Narasimhan, Madhusudhanan, et al.
Publicado: (2021)

Therapeutic Targeting of Hepatic Macrophages for the Treatment of Liver Diseases
por: van der Heide, Daphne, et al.
Publicado: (2019)

The spliceosome, a potential Achilles heel of MYC-driven tumors
por: Anczuków, Olga, et al.
Publicado: (2015)

Janus kinase signaling as risk factor and therapeutic target for severe SARS‐CoV‐2 infection
por: Solimani, Farzan, et al.
Publicado: (2021)

Targeting B cells and plasma cells in autoimmune diseases: From established treatments to novel therapeutic approaches
por: Merino‐Vico, Ana, et al.
Publicado: (2022)

Hydrogen sulfide controls peripheral nerve degeneration and regeneration: a novel therapeutic strategy for peripheral demyelinating disorders or nerve degenerative diseases
por: Jung, Junyang, et al.
Publicado: (2014)

Therapeutic utility of Lung-MAP: ushering into an era of genomic and biomarker-driven clinical trials
por: Zhang, Chenyue, et al.
Publicado: (2021)

Regenerative potential of targeting glycogen synthase kinase-3 signaling in neural tissues
por: Jung, Eui-Man, et al.
Publicado: (2015)

Identifying therapeutic targets for schizophrenia
por: Montague-Cardoso, Karli
Publicado: (2021)

Targeting mitochondria as an anticancer strategy
por: Dong, Lanfeng, et al.
Publicado: (2019)

Microbes are off the menu: Defective macrophage phagocytosis in COPD
por: Walton, Emma Louise
Publicado: (2017)

Targeting metabolic/epigenetic pathways: a potential strategy for cancer therapy in diffuse intrinsic pontine gliomas
por: Zhao, Kun, et al.
Publicado: (2020)

Dietary reprogram of macrophages for cell competition: a promising strategy for malignant cancer control
por: Chen, Jian, et al.
Publicado: (2023)

Linking metabolic and epigenetic regulation in the development of lung cancer driven by TGFβ signaling
por: Zhang, Liyi
Publicado: (2019)

Macrophages assemble! But do they need IL‐4R during schistosomiasis?
por: Rückerl, Dominik, et al.
Publicado: (2019)

Size Matters: Genome Size Dynamics Driven by Copy Number Variation in a Green Alga
por: McGrath, Casey
Publicado: (2023)

Step further towards targeted senolytic therapy: therapeutic potential of uPAR-CAR T cells for senescence-related diseases
por: Huang, Yujia, et al.
Publicado: (2020)

Targeting α7 nicotinic acetylcholine receptors: a future potential for neuroprotection from traumatic brain injury
por: Shin, Samuel S., et al.
Publicado: (2015)

ASGR1: an emerging therapeutic target in hypercholesterolemia
por: Zhao, Wenqi, et al.
Publicado: (2023)

Disrupting redox stabilizer: a novel therapeutic strategy for colorectal cancer
por: Trachootham, Dunyaporn, et al.
Publicado: (2019)

Fa(c)t checking: How fatty acids shape metabolism and function of macrophages and dendritic cells
por: Almeida, Luís, et al.
Publicado: (2021)

Using imaging to combat a pandemic: rationale for developing the UK National COVID-19 Chest Imaging Database
por: Jacob, Joseph, et al.
Publicado: (2020)

New strategies for cancer immunotherapy: targeting regulatory T cells
por: Finotello, Francesca, et al.
Publicado: (2017)

Functional interaction between sensory neurons and mast cells in the early stage of house dust mite-induced type 2 inflammation and itch: a novel therapeutic target of allergic disease
por: Tsang, Miranda Sin-Man, et al.
Publicado: (2020)

Intestinal homeostasis and inflammation: Gut microbiota at the crossroads of pancreas–intestinal barrier axis
por: Zhang, Zhongwei, et al.
Publicado: (2022)

Potential Protein Target to Therapeutically Restore Positive Mood States in Depression
por: Carney, Rosalind S.E.
Publicado: (2019)

Dark side of cyanobacteria: searching for strategies to control blooms
por: Huertas, María José, et al.
Publicado: (2021)

Targeting programmed death ligand 2/repulsive guidance molecule b pathway: a novel strategy to subdue tumor immunotherapy resistance to anti‐programmed death 1/programmed death ligand 1
por: Xiang, Yuancai, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kgcranrk91i2ah7d6j6sfupcb9